相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of co-administration of probiotics and prebiotics on chronic inflammation, and depression symptoms in patients with coronary artery diseases: a randomized clinical trial
Jalal Moludi et al.
NUTRITIONAL NEUROSCIENCE (2022)
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Ling Jin et al.
PROTEIN & CELL (2021)
Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen its Therapeutic Application in Cancer
Phuong H. L. Tran et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis
Xinyu Ge et al.
ADVANCES IN NUTRITION (2020)
Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems
Rubiya Khursheed et al.
DRUG DISCOVERY TODAY (2020)
Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis
Miao-En Yao et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis
Yarong Liu et al.
MEDIATORS OF INFLAMMATION (2020)
Short-chain fatty acid, acylation and cardiovascular diseases
Xiao-Feng Chen et al.
CLINICAL SCIENCE (2020)
TMAO Activates Carotid Endothelial Inflammasomes Leading to Enhanced Neointimal Formation in Nlrp3 Mice
Krishna Boini et al.
FASEB JOURNAL (2020)
Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia
Yuemei Sun et al.
PLOS ONE (2020)
Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
Inaki Robles-Vera et al.
FRONTIERS IN PHYSIOLOGY (2020)
Gut microbiota and cardiovascular disease: opportunities and challenges
Negin Kazemian et al.
MICROBIOME (2020)
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
Lisa Dannenberg et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Ben Arpad Kappel et al.
MOLECULAR METABOLISM (2020)
The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis
Fei Guo et al.
CARDIOLOGY RESEARCH AND PRACTICE (2020)
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Fan Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats
Min Liu et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2019)
The role of intestinal microbiota in cardiovascular disease
Mengchao Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
TMAO and Heart Disease: The New Red Meat Risk?
Jennifer Abbasi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Bringing microbiome-drug interaction research into the clinic
Leah Guthrie et al.
EBIOMEDICINE (2019)
Gut Microbiota and Fecal Levels of Short-Chain Fatty Acids Differ Upon 24-Hour Blood Pressure Levels in Men
Justine Huart et al.
HYPERTENSION (2019)
Gut Microbiome and Response to Cardiovascular Drugs
Sony Tuteja et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
The emerging role of gut microbial metabolism on cardiovascular disease
Kazuyuki Kasahara et al.
CURRENT OPINION IN MICROBIOLOGY (2019)
Treatment strategies against diabetes: Success so far and challenges ahead
Rubiya Khursheed et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
Shengjie Yang et al.
FRONTIERS IN PHARMACOLOGY (2019)
A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis
Eelke Brandsma et al.
CIRCULATION RESEARCH (2019)
L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Robert A. Koeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies
Jiaqian Qi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Drug-gut microbiota interactions: implications for neuropharmacology
Jacinta Walsh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction
Tuo Shao et al.
JOURNAL OF HEPATOLOGY (2018)
Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E-deficient mice
Ying Chen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
Gut Microbiota: An Integral Moderator in Health and Disease
Qingqing Feng et al.
FRONTIERS IN MICROBIOLOGY (2018)
Metabolic Effects of Metformin in the Failing Heart
Aleksandra Dziubak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi Arabia
Abdurrahman Aldiab et al.
BMC PUBLIC HEALTH (2018)
Atorvastatin Treatment Modulates the Gut Microbiota of the Hypercholesterolemic Patients
Tariq Jamal Khan et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2018)
Role of gut microbiota in atherosclerosis
Annika Lindskog Jonsson et al.
NATURE REVIEWS CARDIOLOGY (2017)
Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial
Neda Roshanravan et al.
HORMONE AND METABOLIC RESEARCH (2017)
Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro) renin receptor and intrarenal renin-angiotensin system
Lei Wang et al.
JOURNAL OF HYPERTENSION (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Microbial-dependent TMAO as a prognostic marker in ACS
Irene Fernández-Ruiz
Nature Reviews Cardiology (2017)
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies
Yoriko Heianza et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
Daniele Pastori et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
Takehiro Kamo et al.
PLOS ONE (2017)
Cardiovascular risk factors burden in Saudi Arabia: The Africa Middle East Cardiovascular Epidemiological (ACE) study
Amjad M. Ahmed et al.
JOURNAL OF THE SAUDI HEART ASSOCIATION (2017)
Acrolein Disrupts Tight Junction Proteins and Causes Endoplasmic Reticulum Stress-Mediated Epithelial Cell Death Leading to Intestinal Barrier Dysfunction and Permeability
Wei-Yang Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Cooperative stimulation of atherogenesis by lipopolysaccharide and palmitic acid-rich high fat diet in low-density lipoprotein receptor-deficient mice
Zhongyang Lu et al.
ATHEROSCLEROSIS (2017)
Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure
Chelsea L. Organ et al.
CIRCULATION-HEART FAILURE (2016)
The influence of gut microbiota on drugmetabolismand toxicity
Houkai Li et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin
In Sook Kim et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries
Veronika J. Wirtz et al.
CIRCULATION (2016)
Metformin and the gastrointestinal tract
Laura J. McCreight et al.
DIABETOLOGIA (2016)
Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide
Lili Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Endotoxemia-menace, marker, or mistake?
Robert S. Munford
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
Ming-liang Chen et al.
MBIO (2016)
Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)
Katie A. Meyer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota
Annett Klinder et al.
FOOD & FUNCTION (2016)
Cardiovascular benefits of probiotics: a review of experimental and clinical studies
Ram Mohan Thushara et al.
FOOD & FUNCTION (2016)
Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease
Diede Fennema et al.
DRUG METABOLISM AND DISPOSITION (2016)
Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent
M. Kristina Hamilton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Oral microbiota in patients with atherosclerosis
Frida Fak et al.
ATHEROSCLEROSIS (2015)
The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada
Andrew Mente et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy
Colleen T. Cole-Jeffrey et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure
Nicole Ebner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
Zeneng Wang et al.
EUROPEAN HEART JOURNAL (2014)
Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation
H. Wang et al.
LETTERS IN APPLIED MICROBIOLOGY (2014)
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Michael Lever et al.
PLOS ONE (2014)
Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics
Henry J. Haiser et al.
GUT MICROBES (2014)
NOD proteins: regulators of inflammation in health and disease
Dana J. Philpott et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Serum lipopolysaccharide-binding protein as a marker of atherosclerosis
Marta Serrano et al.
ATHEROSCLEROSIS (2013)
Gut microbiota metabolism of L-carnitine and cardiovascular risk
John R. Ussher et al.
ATHEROSCLEROSIS (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice
Yasuhiro Andoh et al.
IMMUNOBIOLOGY (2013)
L-Carnitine Consumption, Its Metabolism by Intestinal Microbiota, and Cardiovascular Health
Mark F. McCarty
MAYO CLINIC PROCEEDINGS (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A common periodontal pathogen has an adverse association with both acute and stable coronary artery disease
Kati Hyvarinen et al.
ATHEROSCLEROSIS (2012)
Symptomatic atherosclerosis is associated with an altered gut metagenome
Fredrik H. Karlsson et al.
NATURE COMMUNICATIONS (2012)
Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation
Fabienne Laugerette et al.
BIOCHIMIE (2011)
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
K. B. M. Saiful Islam et al.
GASTROENTEROLOGY (2011)
A systematic review of the effectiveness of oral health promotion activities among patients with cardiovascular disease
Otto L. T. Lam et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components
Dulantha Ulluwishewa et al.
JOURNAL OF NUTRITION (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Human oral, gut, and plaque microbiota in patients with atherosclerosis
Omry Koren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: A randomized controlled trial
Caroline Karlsson et al.
ATHEROSCLEROSIS (2010)
Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk
Melania Manco et al.
ENDOCRINE REVIEWS (2010)
Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism
R. Caesar et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Chylomicrons promote intestinal absorption of lipopolysaccharides
Sarbani Ghoshal et al.
JOURNAL OF LIPID RESEARCH (2009)
Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
Luying Peng et al.
JOURNAL OF NUTRITION (2009)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani et al.
DIABETES (2008)
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
P. D. Cani et al.
DIABETOLOGIA (2007)
Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome
Stefan Renvert et al.
JOURNAL OF PERIODONTOLOGY (2006)
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease
SJ Ott et al.
CIRCULATION (2006)
Periodontal disease and coronary heart disease - A reappraisal of the exposure
JD Beck et al.
CIRCULATION (2005)
Antibodies to periodontal pathogens and stroke risk
PJ Pussinen et al.
STROKE (2004)
Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: Expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells
LL Stoll et al.
JOURNAL OF IMMUNOLOGY (2004)
Pathophysiology and biochemistry of cardiovascular disease
J Scott
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Low-level endotoxin induces potent inflammatory activation of human blood vessels - Inhibition by statins
JB Rice et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Chronic infections and the risk of carotid atherosclerosis - Prospective results from a large population study
S Kiechl et al.
CIRCULATION (2001)
分享论文
